Innovative Grade US Origin CD-1 Mouse Serum Reference 8-27-13

Posted by Leanne Kodsman on

Innovative Research's Innovative Grade US Origin CD-1 Mouse Serum was recently used in the following study:

Determination of Androgen Receptor Degradation Enhancer ASC-J9 in Mouse Sera and Organs with Liquid Chromatography Tandem Mass ...

SF Soh, CK Huang, SO Lee, D Xu, S Yeh, J Li, EL Yong... - Journal of Pharmaceutical ..., 2013
Louis, MO, USA). Commercial mouse serum of innovative grade was purchased from Innovative Research Inc. (Peary court Novi, MI, USA). Phosphate buffer saline (PBS) was purchased from Vivantis Technologies Sdn Bhd (Selangor Darul Ehsan, Malaysia).

  • Tags: Animal Serum, Innovative Grade US Origin Mouse CD1 Serum

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!


    Related Posts

    Easy as PAI(-1): Celebrate Pi Day with Cutting-Edge Monoclonal Antibodies from Innovative Research
    In the ever-evolving landscape of molecular biology, precision tools are essential for ...
    Read the Article
    Revolutionizing Diabetes Treatment: Genetically Engineered Pseudo-Islets Achieve Insulin Independence
    In a groundbreaking study, researchers have pioneered a diabetes treatment that could r...
    Read the Article
    Pioneering Advances in Complement-Mediated Disorders: An In-depth Look at SAR443809
    In the dynamic landscape of medical research, SAR443809 emerges as a promising candidat...
    Read the Article

    ← Older Post Newer Post →

    ×